Cargando…

Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

Clinical antimicrobial susceptibility breakpoints are used to predict the clinical outcome of antimicrobial treatment. In contrast, microbiologic breakpoints are used to identify isolates that may be categorized as susceptible when applying clinical breakpoints but harbor resistance mechanisms that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Sue, Bast, Darrin, McGeer, Allison, de Azavedo, Joyce, Low, Donald E.
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2003
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023429/ https://www.ncbi.nlm.nih.gov/pubmed/12890324 http://dx.doi.org/10.3201/eid0907.020589

Ejemplares similares

gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya
por: Kivata, Mary Wandia, et al.
Publicado: (2019)

Mutations in gyrA & parC genes of Shigella flexneri 2a determining the fluoroquinolone resistance
por: Divya, M.P., et al.
Publicado: (2015)

The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran
por: Nouri, Roghayeh, et al.
Publicado: (2016)

Prevalence of fluoroquinolone resistance and mutations in the gyrA, parC and parE genes of Riemerella anatipestifer isolated from ducks in China
por: Zhu, Dekang, et al.
Publicado: (2019)

Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
por: Park, Sunok, et al.
Publicado: (2011)

Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans
por: Casin, Isabelle, et al.
Publicado: (2003)

Resistance Mutations in gyrA and parC are Common in Escherichia Communities of both Fluoroquinolone-Polluted and Uncontaminated Aquatic Environments
por: Johnning, Anna, et al.
Publicado: (2015)

Life-Threatening Infantile Diarrhea from Fluoroquinolone-Resistant Salmonella enteric Typhimurium with Mutations in Both gyrA and parC
por: Nakaya, Hideo, et al.
Publicado: (2003)

1591. Updated Fluoroquinolone MIC Breakpoints: Impact on Susceptibility Rates in the United States
por: Flamm, Robert K, et al.
Publicado: (2019)

1549. Impact of New Fluoroquinolone Breakpoints on Enterobacteriaceae Susceptibility Rates and Clinical Outcomes
por: Pettit, Natasha N, et al.
Publicado: (2019)

Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains
por: Hamasuna, Ryoichi, et al.
Publicado: (2018)

Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta
por: Nathania, Ignes, et al.
Publicado: (2022)

Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam
por: Nguyen, Kinh Van, et al.
Publicado: (2018)

Detection of macrolide and fluoroquinolone resistance-associated 23S rRNA and parC mutations in Mycoplasma genitalium by nested real-time PCR
por: He, Wenyin, et al.
Publicado: (2023)

Molecular Study of Quinolone Resistance Determining Regions of gyrA Gene and parC Genes in Clinical Isolates of Acintobacter baumannii Resistant to Fluoroquinolone
por: Zaki, Maysaa El Sayed, et al.
Publicado: (2018)

Determination of Susceptibility Breakpoint for Cefquinome against Streptococcus suis in Pigs
por: Mi, Kun, et al.
Publicado: (2021)

Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates
por: Shealy, Stephanie C., et al.
Publicado: (2020)

2184. Effect of Adjusted CLSI Breakpoints on Center-wide Fluoroquinolone Susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is It Time to Restrict Empiric Fluoroquinolone Use?
por: Sansom, Sarah, et al.
Publicado: (2019)

The Difficult Case of Crystallization and Structure Solution for the ParC55 Breakage-Reunion Domain of Topoisomerase IV from Streptococcus pneumoniae
por: Sohi, Maninder K., et al.
Publicado: (2008)

A Novel Mismatched PCR-Restriction Fragment Length Polymorphism Assay for Rapid Detection of gyrA and parC Mutations Associated With Fluoroquinolone Resistance in Acinetobacter baumannii
por: Kakuta, Naoki, et al.
Publicado: (2020)

1599. Clinical Outcomes for Patients Treated with Fluoroquinolones for Bacteremia Caused by Enterobacteriaceae Reclassified as Not Susceptible by Updated CLSI Breakpoints
por: Fleischner, Zachary, et al.
Publicado: (2020)

Detection of quinolone-resistance mutations of parC gene in clinical isolates of Acinetobacter baumannii in Iran
por: Vakili, Bahareh, et al.
Publicado: (2014)

Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006)

On the Existence of Step-To-Step Breakpoint Transitions in Accelerated Sprinting
por: Ettema, Gertjan, et al.
Publicado: (2016)

647. Adoption of the updated fluoroquinolones breakpoints for Gram negative bacteria in clinical microbiology laboratories
por: Sfeir, Maroun M
Publicado: (2020)

Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone
por: Pfaller, M. A., et al.
Publicado: (2018)

ParC, a New Partitioning Protein, Is Necessary for the Active Form of ParA From Myxococcus pMF1 Plasmid
por: Sheng, Duohong, et al.
Publicado: (2021)

Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from Brazil
por: Minarini, Luciene A. R., et al.
Publicado: (2012)

The role of Gene Mutations (gyrA, parC) in Resistance to Ciprofloxacin in Clinical Isolates of Pseudomonas Aeruginosa
por: Arabameri, Nasibeh, et al.
Publicado: (2021)

In Vitro Activity of New Cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008–2011
por: Green, Karen, et al.
Publicado: (2014)

Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China
por: Qian, Huimin, et al.
Publicado: (2020)

Linear Regression Equations To Predict β-Lactam, Macrolide, Lincosamide, and Fluoroquinolone MICs from Molecular Antimicrobial Resistance Determinants in Streptococcus pneumoniae
por: Demczuk, Walter, et al.
Publicado: (2022)

J-PARC Symposium 2019
por: Saito, Naohito
Publicado: (2021)

Preparing for physics at J-Parc
Publicado: (2004)

Un parc en automne /
por: Maheux-Forcier, Louise
Publicado: (1982)

PaRC users guide
por: Masso, S, et al.
Publicado: (1993)

Association between mutations in gyrA and parC genes of Acinetobacter baumannii clinical isolates and ciprofloxacin resistance
por: Ardebili, Abdollah, et al.
Publicado: (2015)

Detection of gyrA and parC Mutations and Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Klebsiella pneumoniae
por: Kareem, Sawsan Mohammed, et al.
Publicado: (2021)

Amino acid substitutions in gyrA and parC associated with quinolone resistance in nalidixic acid-resistant Salmonella isolates
por: Bae, Dong Hwa, et al.
Publicado: (2013)

Characterization of gyrA and parC mutations in ciprofloxacin-resistant Pseudomonas aeruginosa isolates from Tehran hospitals in Iran
por: Farahi, Rosetta Moshirian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f1tg0rjqm868b0gk92aqhpapkq